Validus Holdings, Ltd. (VR) Given Consensus Recommendation of “Hold” by Analysts

Validus Holdings, Ltd. (NYSE:VR) has earned an average recommendation of “Hold” from the eleven analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $53.25.

A number of equities analysts have commented on the stock. Barclays dropped their target price on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Monday, October 16th. Zacks Investment Research downgraded shares of Validus from a “hold” rating to a “sell” rating in a research note on Saturday, January 13th. ValuEngine downgraded shares of Validus from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $51.00 target price on shares of Validus in a research note on Thursday, October 12th. Finally, UBS Group upped their target price on shares of Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a research note on Monday, October 30th.

In other news, President Kean Driscoll sold 6,875 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $46.16, for a total transaction of $317,350.00. Following the transaction, the president now directly owns 110,858 shares in the company, valued at $5,117,205.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have sold 20,625 shares of company stock worth $984,775. Insiders own 2.33% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Zions Bancorporation bought a new position in shares of Validus during the third quarter valued at approximately $116,000. The Manufacturers Life Insurance Company boosted its stake in shares of Validus by 10.1% during the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after purchasing an additional 219 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Validus by 1,257.2% during the second quarter. Tower Research Capital LLC TRC now owns 3,678 shares of the insurance provider’s stock valued at $191,000 after purchasing an additional 3,407 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Validus by 4,598.8% during the third quarter. Advisors Asset Management Inc. now owns 3,947 shares of the insurance provider’s stock valued at $194,000 after purchasing an additional 3,863 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Validus by 48.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,315 shares of the insurance provider’s stock valued at $202,000 after acquiring an additional 1,410 shares during the last quarter. Hedge funds and other institutional investors own 93.45% of the company’s stock.

Shares of Validus (VR) traded down $0.01 during mid-day trading on Friday, reaching $67.51. 6,003,563 shares of the company’s stock were exchanged, compared to its average volume of 2,931,098. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95. The company has a market cap of $5,538.99 and a P/E ratio of -103.86. Validus has a twelve month low of $41.15 and a twelve month high of $67.73.

Validus (NYSE:VR) last issued its earnings results on Thursday, February 1st. The insurance provider reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($1.00). The company had revenue of $346.88 million during the quarter, compared to the consensus estimate of $352.00 million. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. Validus’s revenue was up 16.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 earnings per share. analysts expect that Validus will post -0.23 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/02/validus-holdings-ltd-vr-given-consensus-recommendation-of-hold-by-analysts-2.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Analyst Recommendations for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply